Yichang, China

Rong Liu

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Yichang Humanwell Pharmaceuticals Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rong Liu. Retrieved from https://idiyas.com/inventor/rong-liu-jztp8o0j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Rong Liu in Medical Treatment

Introduction

Rong Liu is a notable inventor based in Yichang, China. He has made significant contributions to the field of medical treatment through his innovative research and development. His work primarily focuses on the development of compounds that can aid in treating various medical disorders.

Latest Patents

Rong Liu holds 1 patent for his invention titled "Peptides for treatment of medical disorders." This patent presents compounds that act as selective kappa-opioid receptor agonists. The invention includes methods for preparing these compounds, compositions that comprise them, and methods for treating medical disorders related to kappa-opioid receptor agonists.

Career Highlights

Rong Liu is currently associated with Yichang Humanwell Pharmaceuticals Co., Ltd. His role in the company allows him to further his research and apply his innovative ideas in a practical setting. His work has the potential to impact the medical field significantly.

Collaborations

Rong Liu collaborates with talented individuals such as Subo Liao and Jun Yang. Their combined expertise enhances the research and development efforts within their projects.

Conclusion

Rong Liu's contributions to medical treatment through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work continues to inspire and pave the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…